
TSE:L
This summary was created by AI, based on 13 opinions in the last 12 months.
Loblaw Companies Ltd (L-T) is considered a dominant player in the Canadian grocery and pharmacy markets, with experts highlighting its defensive nature, strong private label offerings, and notable acquisition of Shoppers Drug Mart, which has bolstered its profitability and market share. Despite facing challenges such as food inflation and competitive pressure from major players like Walmart and Costco, the company is seen as having a solid growth trajectory driven by its strong same-store sales and innovative strategies. However, some analysts caution that the stock's recent performance may have led it to become overvalued, suggesting a potential trim for existing investors. While there are mixed views on its short-term appeal amidst a backdrop of rising grocery costs, the company is often recommended for its stability and long-term prospects.
Very few competitors, and those types of names tend to perform well long-term. Largest grocery retailer, so procures good prices and controls distribution. Shoppers Drug Mart provide lots of earnings. Loyalty programs doing well. As a consumer staple, won't participate with more cyclical names. Defensive part of your portfolio. If you're up nicely, you could take some profits.
Likes it. It's an inflation story. Some consumers are gravitating away from restaurants and back to buying their own food, so it's a volume story too. Good place to be. Trading at a reasonable 15x earnings, not overly expensive. If you think we're getting into a mild recession, which might be prolonged, this is a safe bet.
Consumer staples are defensive as we head into a slowing economy. Their discount banners are attracting customer traffic amid inflation. She likes their private labels with 25% customer penetration and strong margins. Great locations. Have benefited from the reopening as people return to the office. Drug stores will play a growing, bigger role in healthcare (Loblaw owns Shoppers Drug Mart and is well-positioned).
(Analysts’ price target is $137.05)
Defensive consumer staple going into economic slowdown. Over half of food banners are in discount, seeing increased traffic. Plus, more people are cooking at home rather than eating out. SDM has great locations, offers Loblaw products; pharmacists expanding roles, and this increases general traffic. Yield is 1.45%.
(Analysts’ price target is $135.40)